A federal jury in Delaware said on Thursday that biotech company Amgen owes competitor Regeneron more than $406 million for ...

In the long-running feud between Regeneron and Amgen around the companies’ competing PCSK9 cholesterol meds, Regeneron has ...

Regeneron Pharmaceuticals won $406.8 million in damages for a lawsuit claiming Amgen violated antitrust and tort laws. A jury in a Delaware court found that Amgen violated certain laws, and gave ...

Led by positive momentum for shares of Cisco and Amgen, the Dow Jones Industrial Average is climbing Thursday afternoon. Shares of Cisco and Amgen have contributed to the blue-chip gauge's intraday ...

It’s been 19 months since Amgen completed its $27.8 billion acquisition of Horizon Therapeutics, and the California company ...

Shares of Amgen (AMGN) have been trending lower with the Health Care sector. But the sell off may soon come to an end.

The Dow Jones Industrial Average is falling Wednesday morning with shares of Amgen and 3M delivering the stiffest headwinds for the blue-chip average. The Dow was most recently trading 115 points ...

Shares of Amgen Inc. AMGN slipped 1.37% to $272.05 Thursday, on what proved to be an all-around positive trading session for ...

Regeneron's lead counsel was Jonathan D. Polkes of White & Case LLP.

Some research has shown that dividend-paying stocks significantly outperformed their non-dividend-paying peers over the past ...

Like fellow Big Pharmas Eli Lilly and Johnson & Johnson, Amgen is urging the Trump administration to consider tax policy ...

Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options ...